Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer

被引:42
|
作者
Fiorentino, A. [1 ]
Caivano, R. [1 ]
Metallo, V. [1 ]
Chiumento, C. [1 ]
Cozzolino, M. [1 ]
Califano, G. [1 ]
Clemente, S. [1 ]
Pedicini, P. [1 ]
Fusco, V. [1 ]
机构
[1] IRCCS CROB, Dept Radiat Oncol, I-85028 Rionero In Vulture, PZ, Italy
关键词
SUBMANDIBULAR-GLANDS; RADIATION-THERAPY; ANATOMIC CHANGES; IMRT; REGISTRATION; XEROSTOMIA; SHRINKAGE; CARCINOMA; SYSTEM; ORGANS;
D O I
10.1259/bjr/30678306
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To evaluate volumetric changes of parotid glands (PGs) during intensity-modulated radiotherapy (IMRT) in head and neck cancer patients. Methods: During IMRT all patients underwent kilovolt cone-beam CT (CBCT) scans to verify the set-up positioning in a protocol study. On each CBCT scan, the PGs were retrospectively contoured and evaluated with a dose-volume histogram. Results: From February to June 2011, 10 patients were enrolled. 140 CBCT scans were registered (280 PGs): for each patient, a median of 14 CBCT scans were performed (range 14-16). At the start of radiation, the average volume for ipsilateral PGs (iPGs) was 18.77 ml (range 12.9-31.2 ml), whereas for contralateral PGs (cPGs) it was 16.63 ml (range 8.3-28.7 ml). At the last CBCT scan, the average volume loss was 43.5% and 44.0% for the iPG and cPG, respectively. When we analysed the percentage of volume loss, we observed that the volume decreased by linear regression (r(2)=0.92 for iPG; r(2)=0.91 for cPG), with an average volume loss rate of 1.5% per day for both PGs. During the third week of treatment the volume of both PGs reduced by 24-30%. Conclusion: Our data show that, during IMRT, the shrinkage of PGs should be taken into account. A replan could be indicated in the third week of radiotherapy.
引用
收藏
页码:1415 / 1419
页数:5
相关论文
共 50 条
  • [41] Can dose reduction to one parotid gland prevent xerostomia? A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy
    Anand, A. K.
    Jain, J.
    Negi, P. S.
    Chaudhoory, A. R.
    Sinha, S. N.
    Choudhury, P. S.
    Kumar, R.
    Munjal, R. K.
    CLINICAL ONCOLOGY, 2006, 18 (06) : 497 - 504
  • [42] LOCAL CONTROL AFTER INTENSITY-MODULATED RADIOTHERAPY FOR HEAD-AND-NECK RHABDOMYOSARCOMA
    Curtis, Amarinthia E.
    Okcu, M. Fatih
    Chintagumpala, Murali
    Teh, Bin S.
    Paulino, Arnold C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (01): : 173 - 177
  • [43] Evidence-based review: Quality of life following head and neck intensity-modulated radiotherapy
    Scott-Brown, Martin
    Miah, Aisha
    Harrington, Kevin
    Nutting, Chris
    RADIOTHERAPY AND ONCOLOGY, 2010, 97 (02) : 249 - 257
  • [44] Alterations in meibomian glands in patients treated with intensity-modulated radiotherapy for head and neck cancer
    Chen, Xiangjun
    Badian, Reza A.
    Hynne, Havard
    Amdal, Cecilie Delphin
    Herlofson, Bente Brokstad
    Utheim, Oygunn Aass
    Westgaard, Kristine Loken
    Fineide, Fredrik
    Jensen, Janicke Liaaen
    Utheim, Tor Paaske
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Volumetric Modulated Arc Therapy for Head and Neck Cancer: A Dosimetric and Treatment Planning Comparison with Intensity Modulated Radiotherapy Techniques
    Goswami, Brijesh
    Yadav, Suresh
    Jain, Rakesh Kumar
    Goswami, Pradeep
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (03)
  • [46] Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: Correlations with parotid dose and quality of life
    Chen, Wen-Cheng
    Lai, Chia-Hsuan
    Lee, Tsair-Fwu
    Hung, Chao-Hsiung
    Liu, Kuo-Chi
    Tsai, Ming-Fong
    Wang, Wen-Hung
    Chen, Hungcheng
    Fang, Fu-Ming
    Chen, Miao-Fen
    ORAL ONCOLOGY, 2013, 49 (01) : 42 - 48
  • [47] Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004-03
    Toledano, Ivan
    Graff, Pierre
    Serre, Antoine
    Boisselier, Pierre
    Bensadoun, Rene-Jean
    Ortholan, Cecile
    Pommier, Pascal
    Racadot, Severine
    Calais, Gilles
    Alfonsi, Marc
    Favrel, Veronique
    Giraud, Philippe
    Lapeyre, Michel
    RADIOTHERAPY AND ONCOLOGY, 2012, 103 (01) : 57 - 62
  • [48] Is Sparing the Deep Lobes of Parotid Gland Necessary on Intensity Modulated Radion Therapy of Head and Neck Cancers?
    Cetin, Eren
    Ozturk, Aysen S.
    Orhun, Haluk
    Baycan, Duygu
    Dogan, Ali
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2012, 22 (02): : 73 - 76
  • [49] Comparison of intensity-modulated radiotherapy and volumetric modulated arc therapy dose measurement for head and neck cancer using optical stimulated luminescence dosimeter
    Lai, Lu-Han
    Chuang, Keh-Shih
    Lin, Hsin-Hon
    Liu, Yi-Chi
    Kuo, Chiung-Wen
    Lin, Jao-Perng
    RADIATION PHYSICS AND CHEMISTRY, 2017, 140 : 266 - 270
  • [50] Dosimetric Comparison of Intensity-Modulated Radiotherapy, Volumetric Modulated Arc Therapy and Hybrid Three-Dimensional Conformal Radiotherapy/Intensity-Modulated Radiotherapy Techniques for Right Breast Cancer
    Liu, Yi-Chi
    Chang, Hung-Ming
    Lin, Hsin-Hon
    Lu, Chia-Chun
    Lai, Lu-Han
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 14